婴幼儿呼吸道合胞病毒感染重症危险因素的研究进展
Advances in the Research on Risk Factors for Severe Infections Caused by Respiratory Syncytial Virus in Infants and Young Children
DOI: 10.12677/acm.2025.1551343, PDF,    科研立项经费支持
作者: 张媛媛, 邓 昱*, 刘恩梅*：重庆医科大学附属儿童医院呼吸科，国家儿童健康与疾病临床医学研究中心，儿童发育疾病研究教育部重点实验室，重庆
关键词: 呼吸道合胞病毒；危险因素；急性下呼吸道感染；Respiratory Syncytial Virus； Risk Factors； Acute Lower Respiratory Tract Infection
摘要: 呼吸道合胞病毒在全球范围内广泛流行，是引起5岁以下儿童急性下呼吸道感染最主要的病毒病原之一。RSV传染性较强，几乎所有儿童在出生后头两年都会发生一次或多次RSV感染。大部分儿童感染RSV后仅表现出轻微至中度的呼吸道症状，但高危婴幼儿(如早产儿、低出生体重儿及患有基础疾病者)中，感染可迅速进展为重症，甚至发生死亡结局。既往已有大量探讨RSV感染重症危险因素的研究，但缺乏系统性的总结更新。目前，长效单克隆抗体Nirsevimab已在国内获批上市，即将广泛应用于婴幼儿RSV预防，明确高危因素对指导RSV被动免疫策略、减轻相关疾病负担至关重要。本文将全面综述婴幼儿RSV感染重症化的主要高危因素，以期为RSV科学防治提供参考。
Abstract: Respiratory syncytial virus (RSV) is one of the most common viral pathogens worldwide causing acute lower respiratory tract infections (ALTI) in children under 5 years of age. RSV is highly contagious, with almost all children developing one or more RSV infections in the first two years of life. Most children infected with RSV show only mild to moderate respiratory symptoms, but in high-risk infants and young children (e.g., preterm infants, low-birth-weight infants, and those with underlying medical conditions), the infection can rapidly progress to severe illness and even fatal outcomes. There have been many studies exploring the risk factors for severe RSV infection, but a systematic summary update is lacking. Nirsevimab, a long-acting monoclonal antibody, has been approved for market use in China and is about to be widely applied in the prevention of RSV in infants and young children. Identifying high-risk factors is crucial for guiding passive immunization strategies for RSV and alleviating the associated disease burden. This article aims to comprehensively review the major high-risk factors for severe RSV infection in infants and young children, with the goal of providing a reference for the scientific prevention and treatment of RSV.
文章引用：张媛媛, 邓昱, 刘恩梅. 婴幼儿呼吸道合胞病毒感染重症危险因素的研究进展[J]. 临床医学进展, 2025, 15(5): 70-77. https://doi.org/10.12677/acm.2025.1551343

参考文献

[1] Duan, Y., Liu, Z., Zang, N., Cong, B., Shi, Y., Xu, L., et al. (2024) Landscape of Respiratory Syncytial Virus. Chinese Medical Journal, 137, 2953-2978. [Google Scholar] [CrossRef] [PubMed]
[2] Glezen, W.P. (1986) Risk of Primary Infection and Reinfection with Respiratory Syncytial Virus. Archives of Pediatrics & Adolescent Medicine, 140, 543-546. [Google Scholar] [CrossRef] [PubMed]
[3] Cardinale, F., Zuccarino, F., Serio, C., Bizzoco, F., Tricarico, L.G., Verriello, G., et al. (2024) Recurrent Respiratory Infections in Children: New Perspectives. Global Pediatrics, 8, Article ID: 100105. [Google Scholar] [CrossRef] 
[4] Deng, S., Cong, B., Edgoose, M., De Wit, F., Nair, H. and Li, Y. (2024) Risk Factors for Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Children under 5 Years: An Updated Systematic Review and Meta-analysis. International Journal of Infectious Diseases, 146, Article ID: 107125. [Google Scholar] [CrossRef] [PubMed]
[5] Li, Y., Wang, X., Blau, D.M., Caballero, M.T., Feikin, D.R., Gill, C.J., et al. (2022) Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger than 5 Years in 2019: A Systematic Analysis. The Lancet, 399, 2047-2064. [Google Scholar] [CrossRef] [PubMed]
[6] Paireau, J., Durand, C., Raimbault, S., Cazaubon, J., Mortamet, G., Viriot, D., et al. (2024) Nirsevimab Effectiveness against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023-January 2024. Influenza and Other Respiratory Viruses, 18, e13311. [Google Scholar] [CrossRef] [PubMed]
[7] Moline, H.L., Toepfer, A.P., Tannis, A., Weinberg, G.A., Staat, M.A., Halasa, N.B., et al. (2025) Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children from 2023-2024. JAMA Pediatrics, 179, 179-187. [Google Scholar] [CrossRef] [PubMed]
[8] Turalde-Mapili, M.W.R., Mapili, J.A.L., Turalde, C.W.R. and Pagcatipunan, M.R. (2023) The Efficacy and Safety of Nirsevimab for the Prevention of RSV Infection among Infants: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics, 11, Article 1132740. [Google Scholar] [CrossRef] [PubMed]
[9] Drysdale, S.B., Cathie, K., Flamein, F., Knuf, M., Collins, A.M., Hill, H.C., et al. (2023) Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. New England Journal of Medicine, 389, 2425-2435. [Google Scholar] [CrossRef] [PubMed]
[10] Domachowske, J., Madhi, S.A., Simões, E.A.F., Atanasova, V., Cabañas, F., Furuno, K., et al. (2022) Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity. New England Journal of Medicine, 386, 892-894. [Google Scholar] [CrossRef] [PubMed]
[11] Jones, J.M., Fleming-Dutra, K.E., Prill, M.M., Roper, L.E., Brooks, O., Sánchez, P.J., et al. (2023) Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR. Morbidity and Mortality Weekly Report, 72, 920-925. [Google Scholar] [CrossRef] [PubMed]
[12] Assad, Z., Romain, A., Aupiais, C., Shum, M., Schrimpf, C., Lorrot, M., et al. (2024) Nirsevimab and Hospitalization for RSV Bronchiolitis. New England Journal of Medicine, 391, 144-154. [Google Scholar] [CrossRef] [PubMed]
[13] Marina Oktapodas, F., Recai, Y., Zhiqing, L., Mary, C., B. Paige, L., Carter H, P., et al. (2023) Trends and Non-Clinical Predictors of Respiratory Syncytial Virus (RSV) and Influenza Diagnosis in an Urban Pediatric Population. International Journal of Pediatric Research, 9, Article 112. [Google Scholar] [CrossRef] [PubMed]
[14] Andeweg, S.P., Schepp, R.M., van de Kassteele, J., Mollema, L., Berbers, G.A.M. and van Boven, M. (2021) Population-based Serology Reveals Risk Factors for RSV Infection in Children Younger than 5 Years. Scientific Reports, 11, Article No. 8953. [Google Scholar] [CrossRef] [PubMed]
[15] Shi, T., Vennard, S., Mahdy, S., Nair, H., Nair, H., Campbell, H., et al. (2021) Risk Factors for Poor Outcome or Death in Young Children with Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis. The Journal of Infectious Diseases, 226, S10-S16. [Google Scholar] [CrossRef] [PubMed]
[16] 徐爱强, 冯录召, 谢正德. 我国婴幼儿呼吸道合胞病毒感染被动免疫预防专家共识[J]. 中国预防医学杂志, 2024, 25(10): 1223-1234.
[17] Hall, C.B., Weinberg, G.A., Blumkin, A.K., Edwards, K.M., Staat, M.A., Schultz, A.F., et al. (2013) Respiratory Syncytial Virus-Associated Hospitalizations among Children Less than 24 Months of Age. Pediatrics, 132, e341-e348. [Google Scholar] [CrossRef] [PubMed]
[18] Gill, C.J., Mwananyanda, L., MacLeod, W.B., Kwenda, G., Pieciak, R., Mupila, Z., et al. (2022) Infant Deaths from Respiratory Syncytial Virus in Lusaka, Zambia from the ZPRIME Study: A 3-Year, Systematic, Post-Mortem Surveillance Project. The Lancet Global Health, 10, e269-e277. [Google Scholar] [CrossRef] [PubMed]
[19] Bont, L., Heijnen, C.J., Kavelaars, A., van Aalderen, W.M.c., Brus, F., Draaisma, J.t.m., et al. (1999) Peripheral Blood Cytokine Responses and Disease Severity in Respiratory Syncytial Virus Bronchiolitis. European Respiratory Journal, 14, 144-149. [Google Scholar] [CrossRef] [PubMed]
[20] Ohuma, E.O., Moller, A., Bradley, E., Chakwera, S., Hussain-Alkhateeb, L., Lewin, A., et al. (2023) National, Regional, and Global Estimates of Preterm Birth in 2020, with Trends from 2010: A Systematic Analysis. The Lancet, 402, 1261-1271. [Google Scholar] [CrossRef] [PubMed]
[21] Iliodromiti, S., Mackay, D.F., Smith, G.C.S., Pell, J.P., Sattar, N., Lawlor, D.A., et al. (2017) Customised and Noncustomised Birth Weight Centiles and Prediction of Stillbirth and Infant Mortality and Morbidity: A Cohort Study of 979,912 Term Singleton Pregnancies in Scotland. PLOS Medicine, 14, e1002228. [Google Scholar] [CrossRef] [PubMed]
[22] Moschino, L., Bonadies, L. and Baraldi, E. (2021) Lung Growth and Pulmonary Function after Prematurity and Bronchopulmonary Dysplasia. Pediatric Pulmonology, 56, 3499-3508. [Google Scholar] [CrossRef] [PubMed]
[23] Abraha, H.Y., Lanctôt, K.L. and Paes, B. (2015) Risk of Respiratory Syncytial Virus Infection in Preterm Infants: Reviewing the Need for Prevention. Expert Review of Respiratory Medicine, 9, 779-799. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, X., Li, Y., Shi, T., Bont, L.J., Chu, H.Y., Zar, H.J., et al. (2024) Global Disease Burden of and Risk Factors for Acute Lower Respiratory Infections Caused by Respiratory Syncytial Virus in Preterm Infants and Young Children in 2019: A Systematic Review and Meta-Analysis of Aggregated and Individual Participant Data. The Lancet, 403, 1241-1253. [Google Scholar] [CrossRef] [PubMed]
[25] Shi, T., Balsells, E., Wastnedge, E., Singleton, R., Rasmussen, Z.A., Zar, H.J., et al. (2015) Risk Factors for Respiratory Syncytial Virus Associated with Acute Lower Respiratory Infection in Children under Five Years: Systematic Review and Meta-Analysis. Journal of Global Health, 5, Article ID: 020416. [Google Scholar] [CrossRef] [PubMed]
[26] Cai, W., Buda, S., Schuler, E., Hirve, S., Zhang, W. and Haas, W. (2020) Risk Factors for Hospitalized Respiratory Syncytial Virus Disease and Its Severe Outcomes. Influenza and Other Respiratory Viruses, 14, 658-670. [Google Scholar] [CrossRef] [PubMed]
[27] Lee, M. and Goh, A. (2021) Mortality in Children Hospitalised with Respiratory Syncytial Virus Infection in Singapore. Singapore Medical Journal, 62, 642-646. [Google Scholar] [CrossRef] [PubMed]
[28] Chatterjee, A., Mavunda, K. and Krilov, L.R. (2021) Current State of Respiratory Syncytial Virus Disease and Management. Infectious Diseases and Therapy, 10, 5-16. [Google Scholar] [CrossRef] [PubMed]
[29] 中华医学会儿科学分会临床药理学组, 中华预防医学会疫苗临床研究专业委员会, 广东省钟南山医学基金会. 人呼吸道合胞病毒下呼吸道感染治疗及预防指南(2024版) [J]. 中华医学杂志, 2024, 104(42): 3867-3888.
[30] Walpert, A.S., Thomas, I.D., Lowe, M.C. and Seckeler, M.D. (2018) RSV Prophylaxis Guideline Changes and Outcomes in Children with Congenital Heart Disease. Congenital Heart Disease, 13, 428-431. [Google Scholar] [CrossRef] [PubMed]
[31] Forman, L.S., Macleod, W., Mwananyanda, L., Kwenda, G., Pieciak, R., Mupila, Z., et al. (2021) Association of Respiratory Syncytial Virus Infection and Underlying Risk Factors for Death among Young Infants Who Died at University Teaching Hospital, Lusaka Zambia. Clinical Infectious Diseases, 73, S180-S186. [Google Scholar] [CrossRef] [PubMed]
[32] Chaw, P.S., Hua, L., Cunningham, S., Campbell, H., Mikolajczyk, R., Nair, H., et al. (2019) Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children with Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis. The Journal of Infectious Diseases, 222, S620-S627. [Google Scholar] [CrossRef] [PubMed]
[33] Antonarakis, S.E., Skotko, B.G., Rafii, M.S., Strydom, A., Pape, S.E., Bianchi, D.W., et al. (2020) Down syndrome. Nature Reviews Disease Primers, 6, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[34] Manzoni, P., Figueras-Aloy, J., Simões, E.A.F., Checchia, P.A., Fauroux, B., Bont, L., et al. (2017) Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection among Children with Chronic Diseases. Infectious Diseases and Therapy, 6, 383-411. [Google Scholar] [CrossRef] [PubMed]
[35] Grut, V., Söderström, L. and Naumburg, E. (2017) National Cohort Study Showed That Infants with Down’s Syndrome Faced a High Risk of Hospitalisation for the Respiratory Syncytial Virus. Acta Paediatrica, 106, 1519-1524. [Google Scholar] [CrossRef] [PubMed]
[36] Beckhaus, A.A. and Castro-Rodriguez, J.A. (2018) Down Syndrome and the Risk of Severe RSV Infection: A Meta-Analysis. Pediatrics, 142, e20180225. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, L., Peeples, M.E., Boucher, R.C., Collins, P.L. and Pickles, R.J. (2002) Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology. Journal of Virology, 76, 5654-5666. [Google Scholar] [CrossRef] [PubMed]
[38] Asner, S., Stephens, D., Pedulla, P., Richardson, S.E., Robinson, J. and Allen, U. (2013) Risk Factors and Outcomes for Respiratory Syncytial Virus-Related Infections in Immunocompromised Children. Pediatric Infectious Disease Journal, 32, 1073-1076. [Google Scholar] [CrossRef] [PubMed]
[39] Ross, H.S., Dallas, R.H., Ferrolino, J.A., Johnson, M.B., Allison, K.J., Cross, S.J., et al. (2024) Clinical Outcomes of Respiratory Syncytial Virus Infection among Pediatric Immunocompromised Hosts. Pediatric Blood & Cancer, 72, e31484. [Google Scholar] [CrossRef] [PubMed]
[40] 中国医药教育协会儿科专业委员会, 中华医学会儿科学分会呼吸学组, 中国医师协会呼吸医师分会儿科呼吸工作委员会, 等. 中国儿童呼吸道合胞病毒感染诊疗及预防指南(2024医生版) [J]. 中华实用儿科临床杂志, 2024, 39(10): 723-732.
[41] Schuurhof, A., Bont, L., Siezen, C.L.E., Hodemaekers, H., van Houwelingen, H.C., Kimman, T.G., et al. (2010) Interleukin‐9 Polymorphism in Infants with Respiratory Syncytial Virus Infection: An Opposite Effect in Boys and Girls. Pediatric Pulmonology, 45, 608-613. [Google Scholar] [CrossRef] [PubMed]
[42] 刘爱良, 鲍燕敏, 李莉, 等. 2020年深圳地区夏季儿童呼吸道合胞病毒感染的流行特征分析[J]. 中国小儿急救医学, 2022, 29(2): 123-127.
[43] Rodríguez, D.A., Rodríguez‐Martínez, C.E., Cárdenas, A.C., Quilaguy, I.E., Mayorga, L.Y., Falla, L.M., et al. (2013) Predictors of Severity and Mortality in Children Hospitalized with Respiratory Syncytial Virus Infection in a Tropical Region. Pediatric Pulmonology, 49, 269-276. [Google Scholar] [CrossRef] [PubMed]
[44] Divarathna, M.V.M., Rafeek, R.A.M., Morel, A.J., Aththanayake, C. and Noordeen, F. (2023) Epidemiology and Risk Factors of Respiratory Syncytial Virus Associated Acute Respiratory Tract Infection in Hospitalized Children Younger than 5 Years from Sri Lanka. Frontiers in Microbiology, 14, Article 1173842. [Google Scholar] [CrossRef] [PubMed]
[45] Kaler, J., Hussain, A., Patel, K., Hernandez, T. and Ray, S. (2023) Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation. Cureus, 15, e36342. [Google Scholar] [CrossRef] [PubMed]
[46] Lee, M.H., Mailepessov, D., Yahya, K., Loo, L.H., Maiwald, M. and Aik, J. (2023) Air Quality, Meteorological Variability and Pediatric Respiratory Syncytial Virus Infections in Singapore. Scientific Reports, 13, Article No. 1001. [Google Scholar] [CrossRef] [PubMed]
[47] Piedimonte, G. (2015) RSV Infections: State of the Art. Cleveland Clinic Journal of Medicine, 82, S13-S18. [Google Scholar] [CrossRef] [PubMed]
[48] 中华医学会儿科学分会临床药理学组, 国家儿童健康与疾病临床医学研究中心, 中华医学会儿科学分会呼吸学组合理用药协作组, 等. 儿童毛细支气管炎管理临床实践指南(2024版) [J]. 中华儿科杂志, 2024, 62(11): 1030-1042.
[49] Mineva, G. and Philip, R. (2023) Impact of Breastfeeding on the Incidence and Severity of Respiratory Syncytial Virus Bronchiolitis in Infants: Systematic Review. Rural and Remote Health, 23, Article 8088. [Google Scholar] [CrossRef] [PubMed]

为你推荐